Paolo Sbraccia

Qualifica
ORDINARIO
Fonte dei dati: Archivio della Ricerca http://art.torvergata.it
  1. Von Schnurbein, J., Adams, C., Akinci, B., Ceccarini, G., D'Apice, M.R., Gambineri, A., et al. (2020). European lipodystrophy registry: Background and structure. ORPHANET JOURNAL OF RARE DISEASES, 15(1), 17. Dettagli
  2. Arriga, R., Pacifici, F., Capuani, B., Coppola, A., Orlandi, A., Scioli, M.G., et al. (2019). Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 9685607. Dettagli
  3. Arriga, R., Pacifici, F., Capuani, B., Coppola, A., Orlandi, A., Scioli, M.G., et al. (2019). Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 9685607. Dettagli
  4. Caterson, I.d., Alfadda, A.a., Auerbach, P., Coutinho, W., Cuevas, A., Dicker, D., et al. (2019). Gaps to bridge: Misalignment between perception, reality and actions in obesity. DIABETES, OBESITY AND METABOLISM, 21(8), 1914-1924. Dettagli
  5. Pacifici, F., Della Morte, D., Capuani, B., Pastore, D., Bellia, A., Sbraccia, P., et al. (2019). Peroxiredoxin6, a Multitask Antioxidant Enzyme Involved in the Pathophysiology of Chronic Noncommunicable Diseases. ANTIOXIDANTS & REDOX SIGNALING, 30(3), 399-414. Dettagli
  6. Cardellini, M., Ballanti, M., Davato, F., Cardolini, I., Guglielmi, V., Rizza, S., et al. (2018). 2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease. ATHEROSCLEROSIS, 277, 179-185. Dettagli
  7. Guglielmi, V., & Sbraccia, P. (2018). Obesity phenotypes: depot-differences in adipose tissue and their clinical implications. EATING AND WEIGHT DISORDERS, 23(1), 3-14. Dettagli
  8. Guglielmi, V., & Sbraccia, P. (2018). Type 2 diabetes: Does pancreatic fat really matter?. DIABETES/METABOLISM RESEARCH AND REVIEWS, 34(2), e2955. Dettagli
  9. Guglielmi, V., Bellia, A., Gentileschi, P., Lombardo, M., D'Adamo, M., Lauro, D., et al. (2018). Parathyroid hormone in surgery-induced weight loss: no glucometabolic effects but potential adaptive response to skeletal loading. ENDOCRINE, 59(2), 288-295. Dettagli
  10. Sbraccia, P., Nisoli, E., & Barazzoni, R. (2018). Obesity: focus on ongoing multidisciplinary and comprehensive research. EATING AND WEIGHT DISORDERS, 23(1), 1-1. Dettagli
  11. Pastore, D., Pacifici, F., Capuani, B., Palmirotta, R., Dong, C., Coppola, A., et al. (2017). Sex-Genetic Interaction in the Risk for Cerebrovascular Disease. CURRENT MEDICINAL CHEMISTRY, 24(24), 2687-2699. Dettagli
  12. Guglielmi, V., D'Adamo, M., Menghini, R., Cardellini, M., Gentileschi, P., Federici, M., et al. (2017). MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects. NUTRITION AND HEALTHY AGING, 4(2), 141-145. Dettagli
  13. Colao, A., Lucchese, M., D'Adamo, M., Savastano, S., Facchiano, E., Veronesi, C., et al. (2017). Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis. BMJ OPEN, 7(2), e013899. Dettagli
  14. Barazzoni, R., Deutz, N., Biolo, G., Bischoff, S., Boirie, Y., Cederholm, T., et al. (2017). Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. CLINICAL NUTRITION, 36(2), 355-363. Dettagli
  15. Guglielmi, V., & Sbraccia, P. (2017). Epicardial adipose tissue: at the heart of the obesity complications. ACTA DIABETOLOGICA, 54(9), 805-812. Dettagli
  16. Guglielmi, V., & Sbraccia, P. (2017). GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products. EATING AND WEIGHT DISORDERS, 22(2), 231-240. Dettagli
  17. Guglielmi, V., Bellia, A., Bianchini, E., Medea, G., Cricelli, I., Sbraccia, P., et al. (2017). Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care. ENDOCRINE, 1-8. Dettagli
  18. Guglielmi, V., Bellia, A., Pecchioli, S., DELLA MORTE, D., Parretti, D., Cricelli, I., et al. (2017). Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care. ATHEROSCLEROSIS, 263, 36-41. Dettagli
  19. Frühbeck, G., Sbraccia, P., Nisoli, E., Woodward, E., Yumuk, V., Farpour-Lambert, N.j., et al. (2016). 2015 Milan Declaration: A Call to Action on Obesity - an EASO Position Statement on the Occasion of the 2015 EXPO. OBESITY FACTS, 9(4), 296-298-298. Dettagli
  20. Arriga, R., Pacifici, F., Capuani, B., Coppola, A., Scioli, M., Pastore, D., et al. (2016). Involvement of PRDX6 in the pathogenesis of obesity and nonalcoholic fatty liver disease. DIABETOLOGIA, 59, S80-S80. Dettagli
  21. Basello, K., Pacifici, F., Capuani, B., Pastore, D., Lombardo, M.f., Ferrelli, F., et al. (2016). Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase. REJUVENATION RESEARCH, 19(1), 79-89. Dettagli
  22. Capuani, B., Pacifici, F., Pastore, D., Palmirotta, R., Donadel, G., Arriga, R., et al. (2016). The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators. PHARMACOLOGICAL RESEARCH, 111, 659-667. Dettagli
  23. Guglielmi, V., Bellia, A., Pecchioli, S., Medea, G., Parretti, D., Lauro, D., et al. (2016). What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database. INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 701-705. Dettagli
  24. Guglielmi, V., Floris, R., D'Adamo, M., Garaci, F., Novelli, G., & Sbraccia, P. (2016). Massive obesity and hyperphagia in posterior bilateral periventricular heterotopias: Case report. BMC MEDICAL GENETICS, 17(1), 18. Dettagli
  25. Guglielmi, V., Maresca, L., Lanzillo, C., Marinoni, G.m., D'Adamo, M., Di Roma, M., et al. (2016). Relationship between regional fat distribution and hypertrophic cardiomyopathy phenotype. PLOS ONE, 11(7), e0158892. Dettagli
  26. Liguori, C., Mercuri, N.B., Izzi, F., Romigi, A., Cordella, A., Piccirilli, E., et al. (2016). Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population. EUROPEAN RESPIRATORY JOURNAL, 47(3), 987-990. Dettagli
  27. Santini, F., Busetto, L., Cresci, B., & Sbraccia, P. (2016). SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO). EATING AND WEIGHT DISORDERS, 21(2), 305-307. Dettagli
  28. Testa, A., Francesconi, A., Giannuzzi, R., Berardi, S., & Sbraccia, P. (2015). Economic analysis of bedside ultrasonography (US) implementation in an Internal Medicine department. INTERNAL AND EMERGENCY MEDICINE. Dettagli
  29. Pastore, D., Della-Morte, D., Coppola, A., Capuani, B., Lombardo, M.f., Pacifici, F., et al. (2015). SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α. CELL DEATH & DISEASE, 6. Dettagli
  30. Guglielmi, V., Cardellini, M., Cinti, F., Corgosinho, F., Cardolini, I., D'Adamo, M., et al. (2015). Omental adipose tissue fibrosis and insulin resistance in severe obesity. NUTRITION & DIABETES, 5(8), e175-e181. Dettagli
  31. CAPUANI, B., DELLA MORTE, D., DONADEL, G., Caratelli, S., Bova, L., PASTORE, D., et al. (2015). Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology. AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM, 308(9), E744-E755. Dettagli
  32. Evangelisti, C., Bernasconi, P., Cavalcante, P., Cappelletti, C., D'Apice, M.R., Sbraccia, P., et al. (2015). Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: Understanding the osteolytic process triggered by altered lamins. ONCOTARGET, 6(10), 7424-7437. Dettagli
  33. Guglielmi, V., D'Adamo, M., Bellia, A., Ciotto, R., Federici, M., Lauro, D., et al. (2015). Iron status in obesity: An independent association with metabolic parameters and effect of weight loss. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 25(6), 541-547. Dettagli
  34. Lauro, D., Pastore, D., Capuani, B., Pacifici, F., Palmirotta, R., Abete, P., et al. (2015). Role of serum and glucocorticoid-inducible kinase (SGK)-1 in senescence: a novel molecular target against age-related diseases. CURRENT MEDICINAL CHEMISTRY, 22(33), 3765-3788. Dettagli
  35. Lombardo, M., Bellia, A., Mattiuzzo, F., Franchi, A., Ferri, C., Elvira, P., et al. (2015). Frequent Follow-Up Visits Reduce Weight Regain in Long-Term Management after Bariatric Surgery. BARIATRIC SURGICAL PRACTICE AND PATIENT CARE, 10(3), 119-125. Dettagli
  36. Lombardo, M., Bellia, A., Mattiuzzo, F., Franchi, A., Ferri, C., Padua, E., et al. (2015). Frequent Follow-Up Visits Reduce Weight Regain in Long-Term Management after Bariatric Surgery. BARIATRIC SURGICAL PRACTICE AND PATIENT CARE, 10(3), 119-125. Dettagli
  37. Guglielmi, V., Maresca, L., D'Adamo, M., Di Roma, M., Lanzillo, C., Federici, M., et al. (2014). Age-Related Different Relationships between Ectopic Adipose Tissues and Measures of Central Obesity in Sedentary Subjects. PLOS ONE, 9(7), e103381-e103381. Dettagli
  38. Ferrelli, F., Pastore, D., Capuani, B., Lombardo, M., Blot Chabaud, M., Coppola, A., et al. (2014). Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia. ACTA DIABETOLOGICA, 52(1), 55-64. Dettagli
  39. Bellia, A., Sallì, M., Lombardo, M., D'Adamo, M., Guglielmi, V., Tirabasso, C., et al. (2014). Effects of whole body vibration plus diet on insulin-resistance in middle-aged obese subjects. INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 35(6), 511-516. Dettagli
  40. Lombardo, M., Bellia, A., Padua, E., Annino, G., Guglielmi, V., D'Adamo, M., et al. (2014). Morning meal more efficient for fat loss in a 3-month lifestyle intervention. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 3(33), 198-205. Dettagli
  41. Donini, L., Grave, R., Caretto, A., Lucchin, L., Melchionda, N., Nisoli, E., et al. (2014). From simplicity towards complexity: the Italian multidimensional approach to obesity. EATING AND WEIGHT DISORDERS. Dettagli
  42. Della-Morte, D., Palmirotta, R., Rehni, A.k., Pastore, D., Capuani, B., Pacifici, F., et al. (2014). Pharmacogenomics and pharmacogenetics of thiazolidinediones: Role in diabetes and cardiovascular risk factors. PHARMACOGENOMICS, 15(16), 2063-2082. Dettagli
  43. Montilla, S., Marchesini, G., Sammarco, A., Trotta, M.p., Siviero, P.d., Tomino, C., et al. (2014). Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 24(12), 1346-1353. Dettagli
  44. Pacifici, F., Arriga, R., Sorice, G., Capuani, B., Scioli, M., Pastore, D., et al. (2014). Peroxiredoxin 6, a novel player in the pathogenesis of diabetes. DIABETES, 63(10), 3210-3220. Dettagli
  45. Weedon, M., Ellard, S., Prindle, M., Caswell, R., Lango Allen, H., Oram, R., et al. (2013). An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. NATURE GENETICS, 45(8), 947. Dettagli
  46. Bellia, A., Garcovich, C., D'Adamo, M., Lombardo, M., Tesauro, M., Donadel, G., et al. (2013). Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. INTERNAL AND EMERGENCY MEDICINE, 8(1), 33-40. Dettagli
  47. Bellia, A., Rizza, S., Lombardo, M., Donadel, G., Fabiano, R., Andreadi, K., et al. (2012). Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy. ATHEROSCLEROSIS, 223(1), 197-203. Dettagli
  48. Casagrande, V., Menghini, R., Marino, A., Marchetti, V., Cavalera, M., Fabrizi, M., et al. (2011). Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 32(1), 74-81. Dettagli
  49. Bellia, A., Marinoni, G., D’Adamo, M., Guglielmi, V., Lombardo, M., Donadel, G., et al. (2012). Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 97(12), 4724-4732. Dettagli
  50. Benedetti, S., Bernasconi, P., Bertini, E., Biagini, E., Capanni, C., Columbaro, M., et al. (2012). The empowerment of translational research: lessons from laminopathies. ORPHANET JOURNAL OF RARE DISEASES, 7(1), 37. Dettagli
  51. Menghini, R., Casagrande, V., Menini, S., Marino, A., Marzano, V., Hribal, M.L., et al. (2012). TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. DIABETES, 61(2), 454-462. Dettagli
  52. Cardellini, M., Menghini, R., Luzi, A., Davato, F., Cardolini, I., D'Alfonso, R., et al. (2011). Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness. DIABETES, 60(12), 3265-3270. Dettagli
  53. Busetto, L., Sbraccia, P., Frittitta, L., & Pontiroli, A. (2011). The growing role of bariatric surgery in the management of type 2 diabetes: evidences and open questions. OBESITY SURGERY, 21(9), 1451-1457. Dettagli
  54. Fiore, A., Marinoni, G.M., Piccione, A., Marini, M.A., D'Adamo, M., Lauro, R., et al. (2011). A rare cardiac finding in a morbidly obese patient with severe hypertension. INTERNAL AND EMERGENCY MEDICINE, 6(3), 241-244. Dettagli
  55. Rizza, S., Cardellini, M., Porzio, O., Pecchioli, C., Savo, A., Cardolini, I., et al. (2011). Pioglitazone improves endothelial and adipose tissue dysfunction in pre-diabetic CAD subjects. ATHEROSCLEROSIS, 215(1), 180-183. Dettagli
  56. Mammi, C., Pastore, D., Lombardo, M., Ferrelli, F., Caprio, M., Consoli, C., et al. (2011). Sildenafil reduces insulin-resistance in human endothelial cells. PLOS ONE, 6(1), e14542-e14542. Dettagli
  57. Shastry, S., Simha, V., Godbole, K., Sbraccia, P., Melancon, S., Yajnik, C.S., et al. (2010). A novel syndrome of mandibular hypoplasia, deafness, and progeroid features associated with lipodystrophy, undescended testes, and male hypogonadism. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 95(10), E192-E197. Dettagli
  58. Santilli, F., Formoso, G., Sbraccia, P., Averna, M., Miccoli, R., Di Fulvio, P., et al. (2010). Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 8(4), 828-837. Dettagli
  59. Bellia, A., Rizza, S., Galli, A., Fabiano, R., Donadel, G., Lombardo, M.f., et al. (2010). Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes. ATHEROSCLEROSIS, 210(1), 199-201. Dettagli
  60. Rizza, S., Tesauro, M., Cardillo, C., Galli, A., Iantorno, M., Gigli, F., et al. (2009). Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. ATHEROSCLEROSIS, 206(2), 569-574. Dettagli
  61. Rizza, S., Tesauro, M., Cardillo, C., Galli, A., Iantorno, M., Gigli, F., et al. (2009). Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. ATHEROSCLEROSIS, 206(2), 569-574. Dettagli
  62. Bellia, A., Giardina, E., Lauro, D., Tesauro, M., Di Fede, G., Cusumano, G., et al. (2009). The Linosa Study: epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 19(7), 455-461. Dettagli
  63. Bellia, A., Giardina, E., Lauro, D., Tesauro, M., Di Fede, G., Cusumano, G., et al. (2009). "The Linosa Study": Epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 19(7), 455-461. Dettagli
  64. Rizza, S., Tesauro, M., Cardillo, C., Galli, A., Iantorno, M., Gigli, F., et al. (2009). Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. ATHEROSCLEROSIS, 206(2), 569-574. Dettagli
  65. Lombardi, F., Fasciglione, G., D'Apice, M., Vielle, A., D'Adamo, M., Sbraccia, P., et al. (2008). Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome. CLINICAL GENETICS, 74(4), 374-383. Dettagli
  66. Lombardi, F., Gullotta, F., Columbaro, M., Filareto, A., D'Adamo, M., Vielle, A., et al. (2007). Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 92(11), 4467-4471. Dettagli
  67. Serino, M., Menghini, R., Fiorentino, L., Amoruso, R., Mauriello, A., Lauro, D., et al. (2007). Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. DIABETES, 56(10), 2541-2546. Dettagli
  68. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432. Dettagli
  69. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432. Dettagli
  70. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M.A., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432. Dettagli
  71. Menghini, R., Marchetti, V., Cardellini, M., Hribal, M., Mauriello, A., Lauro, D., et al. (2005). Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. CIRCULATION, 111(15), 1946-1953. Dettagli
  72. Federici, M., Hribal, M., Menghini, R., Kanno, H., Marchetti, V., Porzio, O., et al. (2005). Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. THE JOURNAL OF CLINICAL INVESTIGATION, 115(12), 3494-3505. Dettagli
  73. SBRACCIA P, D.M. (2004). Obesity and anorexia as neuroendocrine disorders.. In C.F. Baldelli R (a cura di), Update in Neuroendocrinology. Pubblicazioni Medico Scientifiche. Dettagli
  74. D'Adamo, M., Perego, L., Cardellini, M., Marini, M.A., Frontoni, S., Andreozzi, F., et al. (2004). The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. DIABETES, 53(7), 1905-1910. Dettagli
  75. Amati, F., Biancolella, M., D'Apice, M.R., Gambardella, S., Mango, R., Sbraccia, P., et al. (2004). Gene expression profiling of fibroblasts from a human progeroid disease mandibuloacral dysplasia, MAD #248370 through cDNA microarrays. GENE EXPRESSION, 12(1), 39-47. Dettagli
  76. Sesti, G., Cardellini, M., Marini, M., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-1283. Dettagli
  77. Sesti, G., Cardellini, M., Marini, M., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-3. Dettagli
  78. Sesti, G., Cardellini, M., Marini, M.A., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-1283. Dettagli
  79. Sesti G., C.M. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES. Dettagli
  80. Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D'Apice, M.R., Massart, C., et al. (2002). Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. AMERICAN JOURNAL OF HUMAN GENETICS, 71(2), 426-431. Dettagli
  81. Federici, M., Menghini, R., Mauriello, A., Hribal, M., Ferrelli, F., Lauro, D., et al. (2002). Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. CIRCULATION, 106(4), 466-472. Dettagli
  82. Federici, M., Menghini, R., Mauriello, A., Hribal, M.L., Ferrelli, F., Lauro, D., et al. (2002). Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. CIRCULATION, 106(4), 466-472. Dettagli
  83. Menghini, R., Hribal, M.L., Mauriello, A., Ferrelli, F., Lauro, D., Sbraccia, P., et al. (2002). Hyperglycemia induces pro-atherosclerotic events through O-linked-glycosylation modification of insulin signaling proteins. DIABETES, 51(supp 2), A178-A178. Dettagli
  84. Sbraccia P., D.M. (2002). Relationship between plasma free fatty acids and uncoupling protein-3 gene expression in skeletal muscle of obese subjects: in vitro evidence of a causal link. CLINICAL ENDOCRINOLOGY, 57(2), 199-207. Dettagli
  85. Sesti, G., Federici, M., Hribal, M., Lauro, D., Sbraccia, P., & Lauro, R. (2001). Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB JOURNAL, 15(12), 2099-2111. Dettagli
  86. Sesti, G., Federici, M., Hribal, M.l., Lauro, D., Sbraccia, P., & Lauro, R. (2001). Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. THE FASEB JOURNAL, 15(12), 2099-2111. Dettagli
  87. Frittitta, L., Sbraccia, P., Costanzo, B.V., Tassi, V., D'Adamo, M., Spampinato, D., et al. (2000). High insulin levels do not influence PC-1 gene expression and protein content in human muscle tissue and hepatoma cells. DIABETES/METABOLISM RESEARCH AND REVIEWS, 16(1), 26-32. Dettagli
  88. Giovannone, B., Scaldaferri, M., Federici, M., Porzio, O., Lauro, D., Fusco, A., et al. (2000). Insulin receptor substrate (IRS) transduction system: Distinct and overlapping signaling potential. DIABETES/METABOLISM RESEARCH AND REVIEWS, 16(6), 434-441. Dettagli
  89. Federici, M., Lauro, D., D'Adamo, M., Giovannone, B., Porzio, O., Mellozzi, M., et al. (1998). Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia. DIABETES, 47(1), 87-92. Dettagli
  90. D'Adamo, M., Buongiorno, A., Maroccia, E., Leonetti, F., Barbetti, F., Giaccari, A., et al. (1998). Increased OB gene expression leads to elevated plasma leptin concetrations in patients with chronic primary hyperinsulinemia. DIABETES. Dettagli
  91. Barbetti, F., Rocchi, M., Bossolasco, M., Cordera, R., Sbraccia, P., Finelli, P., et al. (1996). The human skeletal muscle glycogenin gene: cDNA, tissue expression, and chromosomal localization. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 220(1), 72-77. Dettagli